ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
38 hedge funds and large institutions have $21M invested in Oncternal Therapeutics, Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
9% more funds holding
Funds holding: 35 → 38 (+3)
Holders
38
Holding in Top 10
–
Calls
$53K
Puts
$43K
Top Buyers
| 1 | +$134K | |
| 2 | +$105K | |
| 3 | +$68.4K | |
| 4 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
+$66K |
| 5 |
D.E. Shaw & Co
New York
|
+$62K |
Top Sellers
| 1 | -$498K | |
| 2 | -$42K | |
| 3 | -$26K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$23.4K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$12.4K |